Jeffery Fairman,Gary H. Cohen,Roselyn J. Eisenberg
申请号：
US13578976
公开号：
US09089537B2
申请日:
2011.02.25
申请国别(地区):
US
年份:
2015
代理人:
摘要：
The present disclosure generally relates to vaccine compositions for Herpes Simplex Viruses (HSV) types 1 and/or 2. The vaccines comprise isolated antigens or glycoprotein subunits of the viruses, optionally with an adjuvant, such as a cationic liposome DNA complex (CLDC). Also the present disclosure contains methods of vaccinating a subject utilizing these compositions.
